Literature DB >> 12224088

Enhancing the antitumoral effect of hypericin-mediated photodynamic therapy by hyperthermia.

Bin Chen1, Tania Roskams, Peter A M de Witte.   

Abstract

BACKGROUND AND OBJECTIVES: In the previous study, we have found a synergistic effect on the RIF-1 tumor cell killing when hypericin-mediated photodynamic therapy (PDT) was combined with hyperthermia. The purpose of the present study was to investigate the antitumoral effect of hypericin-PDT in combination with hyperthermia in the RIF-1 mouse tumor model. STUDY DESIGN/
MATERIALS AND METHODS: Tumor response to PDT in combination with hyperthermia was compared to the response to PDT or hyperthermia alone. To explore the possible mechanism involved in the interaction of PDT and hyperthermia, we determined the tumor cell survival by in vivo/in vitro cell survival assay and analyzed the functional blood vessels by Hoechst 33342 staining. The mode of cell death was examined by TUNEL assay.
RESULTS: Enhanced tumor response was obtained by PDT immediately followed by hyperthermia. Tumor cell survival assay revealed that indirect vascular effect contributed greatly to the overall tumor cell death induced by PDT with hypericin, whereas direct tumor cytotoxicity played a major role in hyperthermia-induced tumor cell killing. Combining PDT with hyperthermia brought about a synergistic interaction on direct tumor cell killing. Even though PDT or hyperthermia alone induced severe blood vessel shutdown and the combined treatments led to significant potentiation of the vascular damage as examined by Hoechst staining, the gain in tumor cell death as a result of this secondary vascular effect was limited after the combined treatments. Following the cellular damage by PDT in combination with hyperthermia, tumor cells were triggered to undergo apoptosis.
CONCLUSIONS: Our study demonstrated the possibility of using hyperthermia to potentiate the antitumoral effect of hypericin-mediated PDT. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224088     DOI: 10.1002/lsm.10089

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  5 in total

1.  Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids.

Authors:  Henry Hirschberg; Chung-Ho Sun; Bruce J Tromberg; Alvin T Yeh; Steen J Madsen
Journal:  J Neurooncol       Date:  2004-12       Impact factor: 4.130

2.  Time and dose dependence of pluronic bioactivity in hyperthermia-induced tumor cell death.

Authors:  Tianyi M Krupka; David Dremann; Agata A Exner
Journal:  Exp Biol Med (Maywood)       Date:  2008-11-07

3.  Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.

Authors:  Donghui Ju; Fumio Yamaguchi; Guangzhi Zhan; Tadashi Higuchi; Takayuki Asakura; Akio Morita; Hideo Orimo; Shaoshan Hu
Journal:  Tumour Biol       Date:  2016-02-04

4.  Enhanced antiproliferative and apoptotic response of HT-29 adenocarcinoma cells to combination of photoactivated hypericin and farnesyltransferase inhibitor manumycin A.

Authors:  Veronika Sačková; Lucia Kuliková; Martin Kello; Ivana Uhrinová; Peter Fedoročko
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

5.  Sequential systemic administrations of combretastatin A4 Phosphate and radioiodinated hypericin exert synergistic targeted theranostic effects with prolonged survival on SCID mice carrying bifocal tumor xenografts.

Authors:  Junjie Li; Marlein Miranda Cona; Feng Chen; Yuanbo Feng; Lin Zhou; Guozhi Zhang; Johan Nuyts; Peter de Witte; Jian Zhang; Jie Yu; Raymond Oyen; Alfons Verbruggen; Yicheng Ni
Journal:  Theranostics       Date:  2013-02-13       Impact factor: 11.556

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.